Pharmacy
Home Pharmacy
Lasting Outcomes for Imatinib in Chronic Myeloid Leukemia
Estimated overall survival 83.3 percent at 10 years for patients in imatinib treatment group
Drug Shortages Affecting Emergency Med Up 2008 to 2014
Increases seen in drugs used as direct lifesaving intervention or for high acuity conditions
Implementation of ‘Treat All’ Did Not Increase ART Coverage for Children
Implementation did not accelerate ART coverage gains or AIDS mortality reductions among pediatric patients
ADHD Tied to Higher Fracture Risk in Children
However, pharmacological treatment for ADHD may decrease this risk
ADA 2019 Standards of Care Emphasize Patient-Centered Care
Updates include use of SGLT-2 inhibitors and GLP-1 receptor agonists for T2DM, CVD; endorsed by ACC
$26 Billion Settlement Offer in Opioid Lawsuits Gains Support
According to the general outline of the plan, distributors will pay about $21 billion over 18 years
Interest in Marijuana, Cannabinoids for Pain Rising Rapidly
Physician anesthesiologists concerned about prevalent misunderstanding about marijuana, related products
BNT162b2 Highly Effective Against Delta Variant in Teens
At seven to 21 days after second dose, estimated effectiveness was 90 percent against infection, 93 percent against symptomatic COVID-19
Vaccine-Chemotherapy Combo Promising in Glioblastoma
Four of the 11 patients in study survived for more than five years after vaccine/chemo treatment
Only Four in 10 With Severe Asthma See Specialist
Lower health care utilization seen in 12 months following first specialist visit
